お知らせ
-
High-precision rapid testing of omicron SARS-CoV-2 variants in clinical samples using AI-nanopore
Kaoru Murakami, Shimpei I Kubota, Kumiko Tanaka, Hiroki… 続きを読む
-
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics
Izumi Kimura, Daichi Yamasoba, Hesham Nasser, Hayato It… 続きを読む
-
Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study
Takaya Ichikawa, Tomokazu Tamura, Mutsumi Takahata, Tak… 続きを読む
-
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study
Wataru Akahata, Takashi Sekida, Takuto Nogimori, Hirota… 続きを読む
-
Inhibitors of cannabinoid receptor 1 suppress the cellular entry of Lujo virus
Miyuki Kimura, Risa Matsuoka, Satoshi Taniguchi, Junki … 続きを読む
-
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
Tomokazu Tamura, Daichi Yamasoba, Yoshitaka Oda, Jumpei… 続きを読む
-
Impact of imprinted immunity induced by mRNA vaccination in an experimental animal model
Shigeru Fujita, Keiya Uriu, Lin Pan, Naganori Nao, Kosh… 続きを読む
-
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern
Mai Komori, Takuto Nogimori, Amber L Morey, Takashi Sek… 続きを読む
-
A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
Takahiro Tomiyama, Rigel Suzuki, Noboru Harada, Tomokaz… 続きを読む
-
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, Jiri Zahradnik… 続きを読む
